Beta: Sign in
Shares outstandingAs of 2026-07-29 · filed common shares: 42.89M
Shares float: Sign in
Float %: Sign in
Insider ownershipDirectors and officers, from their latest Form 3/4/5 holding: 0.14%
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 4.80%
Short ratioDays to cover, as published by FINRA: 4.81
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 66.80%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 70.00%
Avg volume (10D)

See the full stock page

Prices, charts, ranges, valuation ratios, dividends, momentum and analyst estimates are licensed for signed-in members. A free account opens every stock, fund and crypto page.

Create free account

Source: SEC filings. Information and analytics, not investment advice.

Rev growth (fwd)

Avg volume (3 months)

Profitability

Gross marginTTM to Jun 26: 86.14%
Operating marginTTM to Jun 26: 44.44%
Net margin: —
EBITDA marginTTM to Jun 26: 47.34%
Return on equityNet income (TTM to Jun 26) ÷ average shareholders equity: 19.32%
Return on assetsNet income (TTM to Jun 26) ÷ average total assets: 17.33%

Growth

Revenue growth (annual YoY): 10.61%
Revenue growth (latest qtr YoY): -1.92%
Revenue growth (fwd): Sign in
Net income growth (annual YoY)FY Dec 25 vs FY Dec 24: 11.68%
Net income growth (latest qtr YoY): 7.59%
EPS growth (fwd): Sign in
Net income growth (QoQ): 21.14%

Valuation

Market cap: Sign in
Enterprise value: Sign in
P/E: Sign in
P/E (fwd): Sign in
PEG: Sign in
PEG (fwd): Sign in
Price / book: Sign in
Price / sales

Price / operating cash flow

P/FCF

EV / revenue

EV / EBITDA

EPSDiluted, TTM to Jun 26

27.91

EPS (fwd)

Financial health

Cash & equivalentsas of Jun 26: $1.80B
Total cash: Sign in
Total debt: —
Debt / equity: —
Current ratioas of Jun 26: 5.73
Quick ratio(Cash + marketable securities + receivables) ÷ current liabilities, as of Jun 26: 4.89
Operating cash flowTTM to Jun 26: $1.68B
Free cash flowUnadjusted FCF = CFO − capex · TTM to Jun 26: $1.09B
TTM revenue / diluted shareDiluted, TTM to Jun 26: 67.22

UTHR stock Statistics — UNITED THERAPEUTICS Corp filings, insiders & smart money · Instaport